Full Press Release Details
Director s Interest Notice
Change of Director s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX s property and
Introduced 30/9/2001.
| Name of Entity: | PRIMA BIOMED LIMITED (ASX:PRR) | |
| ACN: | 90 009 237 889 |
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes
of section 205G of the Corporations Act.
| Name of Director: | Mr Marc Voigt | |
| Date of Last Notice: | 15 July 2014 |
Part 1 Change of director s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of notifiable interest of a director should be
disclosed in this part.
| Direct or indirect interest | Direct | |
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | N/A | |
| Date of change | 02 January 2015 |
| + See chapter 19 for defined terms. | ||
| 11/3/2002 | Appendix 3Y Page 1 |
Change of Director s Interest Notice
| Shares | Options | |||||||
| Direct | 720,000 | 1,171,754 | ||||||
| Indirect | ||||||||
| Total | 720,000 | 1,171,754 |
| Shares | Options | |||||||
| Direct | 150 | |||||||
| Indirect | ||||||||
| Total | 150 |
| Class | Ordinary Fully Paid Shares | |
| Number acquired | 1) Ordinary Fully Paid Shares |
| Shares | Options | |||||||
| Direct | 150,000 | |||||||
| Indirect | ||||||||
| Total | 150,000 |
| Number disposed | Nil | |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | A$ 5,100 |
| + See chapter 19 for defined terms. | ||
| Appendix 3Y Page 2 | 11/3/2002 |
Change of Director s Interest Notice
| Shares | Options | |||||||
| Direct | 870,000 | 1,171,754 | ||||||
| Indirect | ||||||||
| Total | 870,000 | 1,171,754 |
| Shares | Options | |||||||
| Direct | 150 | |||||||
| Indirect | ||||||||
| Total | 150 |
| 3) 4,068,627 STI Performance Rights and 12,254,902 LTI Performance Rights in accordance with shareholder approval obtained at 2014 AGM. | ||
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Acquiring 150,000 fully paid ordinary shares on market at $0.034 each. |
Part 2 Change of director s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of notifiable interest of a director should be
disclosed in this part.
| Detail of contract | N/A | |
| Nature of interest | ||
| Name of registered holder (if issued securities) | ||
| Date of change | ||
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | ||
| Interest acquired | ||
| Interest disposed | ||
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | ||
| Interest after change |
Part 3 +Closed Period
| Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No | |
| If so, was prior written clearance provided to allow the trade to proceed during this period? | ||
| If prior written clearance was provided on what date was this provided? |
| + See chapter 19 for defined terms. | ||
| 11/3/2002 | Appendix 3Y Page 3 |